Citadel Advisors’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4K | Buy |
+21,369
| New | +$27.4K | ﹤0.01% | 5592 |
|
|
2025
Q1 | – | Sell |
-15,891
| Closed | -$29.7K | – | 6214 |
|
|
2024
Q4 | $29.7K | Buy |
+15,891
| New | +$29.7K | ﹤0.01% | 5577 |
|
|
2024
Q3 | – | Sell |
-2,371
| Closed | -$15.4K | – | 6027 |
|
|
2024
Q2 | $15.4K | Sell |
2,371
-3,620
| -60% | -$23.5K | ﹤0.01% | 5458 |
|
|
2024
Q1 | $44.3K | Buy |
5,991
+319
| +6% | +$2.36K | ﹤0.01% | 5347 |
|
|
2023
Q4 | $47.6K | Buy |
5,672
+2,923
| +106% | +$24.5K | ﹤0.01% | 5136 |
|
|
2023
Q3 | $16.1K | Buy |
2,749
+1,539
| +127% | +$9.01K | ﹤0.01% | 5353 |
|
|
2023
Q2 | $12.9K | Sell |
1,210
-4,483
| -79% | -$48K | ﹤0.01% | 5337 |
|
|
2023
Q1 | $35.9K | Sell |
5,693
-2,760
| -33% | -$17.4K | ﹤0.01% | 5266 |
|
|
2022
Q4 | $59.2K | Sell |
8,453
-1,217
| -13% | -$8.52K | ﹤0.01% | 5221 |
|
|
2022
Q3 | $80K | Buy |
+9,670
| New | +$80K | ﹤0.01% | 5176 |
|
|
2022
Q2 | – | Sell |
-1,524
| Closed | -$20K | – | 6248 |
|
|
2022
Q1 | $20K | Sell |
1,524
-8,546
| -85% | -$112K | ﹤0.01% | 6133 |
|
|
2021
Q4 | $165K | Buy |
10,070
+2,534
| +34% | +$41.5K | ﹤0.01% | 5607 |
|
|
2021
Q3 | $199K | Sell |
7,536
-3,825
| -34% | -$101K | ﹤0.01% | 5427 |
|
|
2021
Q2 | $388K | Sell |
11,361
-3,915
| -26% | -$134K | ﹤0.01% | 4956 |
|
|
2021
Q1 | $770K | Buy |
+15,276
| New | +$770K | ﹤0.01% | 4174 |
|
|
2019
Q4 | – | Sell |
-1,938
| Closed | -$31K | – | 4750 |
|
|
2019
Q3 | $31K | Buy |
+1,938
| New | +$31K | ﹤0.01% | 4444 |
|
|
2019
Q1 | – | Sell |
-1,385
| Closed | -$28K | – | 4656 |
|
|
2018
Q4 | $28K | Buy |
+1,385
| New | +$28K | ﹤0.01% | 4187 |
|